Medicines in ATC group L — Antineoplastic and immunomodulating agents

Overview of medicines in ATC class L (Antineoplastic and immunomodulating agents) and their availability in Belgian pharmacies.

1878 medicines

• Teysuno 20 mg - 5.8 mg - 15.8 mg — tegafur 20 mg + gimeracil 5,8 mg + oteracil 15,8 mg capsule (or.)
• Thalidomide BMS 50 mg — thalidomide
• Thiotepa Riemser 100 mg — thiotepa
• Thiotepa Riemser 15 mg — thiotepa
• Thymoglobuline 5 mg/ml — immunoglobulinen, anti-T-lymfocyten
• Tibsovo 250 mg — ivosidenib
• Tomudex 2 mg — raltitrexed
• Topotecan Accord Healthcare 1 mg/ml — topotecan
• Topotecan Accord Healthcare 1 mg/ml
• Topotecan Mylan 1 mg/ml
• Topotecan Mylan 1 mg/ml
• Topotecan Teva 1 mg/1 ml
• Torisel 30 mg
• Trabectedin Accord 0.25 mg — trabectedine
• Trabectedin Accord 1 mg — trabectedine
• Trabectedin Ever Pharma 0.25 mg — trabectedine
• Trabectedin Ever Pharma 1 mg — trabectedine
• Trabectedine Teva 0.25 mg — trabectedine
• Trabectedine Teva 1 mg — trabectedine
• Trazimera 420 mg — trastuzumab
• Trazimera 150 mg — trastuzumab
• Trecondi 1 g — treosulfan
• Trecondi 5 g — treosulfan
• Tremfya 100 mg — guselkumab
• Tremfya 100 mg — guselkumab
• Tremfya 100 mg — guselkumab
• Tremfya 200 mg — guselkumab
• Tremfya 200 mg — guselkumab
• Tremfya 200 mg — guselkumab
• Tremfya 45 mg/0.45 ml — guselkumab
• Trisenox 1 mg/ml
• Trisenox 2 mg/ml — arseentrioxide
• Trodelvy 200 mg — sacituzumab govitecan
• Truqap 160 mg — capivasertib
• Truqap 200 mg — capivasertib
• Truxima 100 mg — rituximab
• Truxima 100 mg — rituximab
• Truxima 500 mg — rituximab
• Truxima 500 mg — rituximab
• Tukysa 150 mg — tucatinib
• Tukysa 50 mg — tucatinib
• Tyenne 162 mg — tocilizumab
• Tyenne 162 mg — tocilizumab
• Tyenne 162 mg — tocilizumab
• Tyenne 162 mg — tocilizumab
• Tyenne 20 mg/ml — tocilizumab
• Tyenne 20 mg/ml — tocilizumab
• Tyenne 20 mg/ml — tocilizumab
• Tysabri 150 mg — natalizumab
• Tysabri 300 mg — natalizumab
• Tyverb 250 mg — lapatinib
• Ultomiris 1100 mg/11 ml — ravulizumab
• Ultomiris 300 mg/3 ml — ravulizumab
• Usymro 45 mg — ustekinumab
• Usymro 90 mg — ustekinumab
• Uzpruvo 45 mg — ustekinumab
• Uzpruvo 90 mg — ustekinumab
• Vanflyta 17.7 mg — quizartinib
• Vanflyta 26.5 mg — quizartinib
• Vargatef 100 mg — nintedanib